Abstract
Oxidative stress induced by long-term glucocorticoid (GC) use weakens the repair capacity of bone tissue. Nicotinamide adenine dinucleotide phosphate, reduced form (NADPH) oxidase (NOX) is a superoxide-generating enzyme that plays an important role in regulating bone metabolism. To clarify the role of nonphagocytic NOX isoforms in osteoblast reactive oxygen species (ROS) generation and apoptosis, dexamethasone was used to establish a high-dose GC environment in vitro. A dose-dependent increase in intracellular ROS generation was demonstrated, which was accompanied by increased osteoblastic MC3T3-E1 cell apoptosis. Addition of the ROS inhibitor NAC (N-acetyl-L-cysteine) or NOX inhibitor DPI (diphenyleneiodonium) reversed this effect, indicating that NOX-derived ROS can induce osteoblast apoptosis under high-dose dexamethasone stimulation. NOX1, NOX2, and NOX4 are NOX homologs recently identified in bone tissue. To clarify the NOX isoforms that play a role in osteoblast ROS generation, Nox1, Nox2, and Nox4 mRNA expression and NOX2 and NOX4 protein expression were analyzed. Nox1 and Nox4 mRNA expression was elevated in a dose-dependent manner after culture in 100 nM, 250 nM, 500 nM, or 1000 nM dexamethasone, and the increased expression of NOX1 mRNA was more significant compared with NOX4 mRNA. Small interfering RNAs (siRNAs) were used to confirm the role of NOX1 and NOX4 in ROS generation. To clarify the signaling pathway in ROS-induced osteoblast apoptosis, mitogen-activated protein kinase (MAPK) signaling molecules were analyzed. Phosphorylated ASK1 and p38 levels were significantly higher in the 1000 nM dexamethasone group, which NAC or DPI markedly attenuated. However, the total mRNA and protein levels of ASK1 and p38 between the dexamethasone group and control were not significantly different. This is related to ROS regulating the posttranslational modification of ASK1 and p38 in MC3T3-E1 cell apoptosis. Altogether, NOX1- and NOX4-derived ROS plays a pivotal role in high-dose dexamethasone-induced preosteoblast apoptosis by increasing phosphorylated ASK1 and p38 and may be an important mechanism in steroid-induced avascular necrosis of the femoral head (SANFH).
Highlights
Glucocorticoids (GCs) are clinically prescribed antiinflammatory and immunosuppressive medicine for treating many diseases
Over the last decade, accumulating evidence has demonstrated the strong association between osteocyte and osteoblast apoptosis with steroid-induced avascular necrosis of the femoral head (SANFH) [2,3,4]
We report osteoblastic MC3T3-E1 cell apoptosis induced by oxidative injury in a high-dose DEX environment
Summary
Glucocorticoids (GCs) are clinically prescribed antiinflammatory and immunosuppressive medicine for treating many diseases. Over the last decade, accumulating evidence has demonstrated the strong association between osteocyte and osteoblast apoptosis with steroid-induced avascular necrosis of the femoral head (SANFH) [2,3,4]. After long-term usage of high-dose GCs, cumulative and irreparable vascular compromise and osteoblast apoptosis will occur, which could affect the balance of bone metabolism [6]. NOX/NADPH oxidase isoform involvement in the pathogenesis of ROS generation and the apoptosis signaling molecules in osteoblasts induced by high-dose dexamethasone (DEX) has not been fully clarified. This prompted our investigation of whether NOX1-, NOX2-, or NOX4-derived ROS can affect osteoblast apoptosis through MAPK signaling molecules in a high-dose DEX environment.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.